All are true about Tocilizumab except:

A Tocilizumab is a humanized monoclonal antibody directed against the membrane and soluble forms of the IL-6 receptor.
B It has been shown to decrease LDL cholesterol.
C Tocilizumab has been associated with an increased risk of infection, neutropenia, and Thrombocytopenia.
D The hematologic abnormalities appear to be reversible upon stopping the drug.



Free Practice Tests 10 Tests

Prepared for related topics